Dissecting Variation in Biomass Conversion Factors across China’s Forests: Implications for Biomass and Carbon Accounting

ανά Luo, Yunjian, Zhang, Xiaoquan, Wang, Xiaoke, Ren, Yin
Έκδοση 2014

Overexpression of NtDOG1L-T Improves Heat Stress Tolerance by Modulation of Antioxidant Capability and Defense-, Heat-, and ABA-Related Gene Expression in Tobacco

ανά Dai, Xiaoyan, Wang, Yingfeng, Chen, Yanchun, Li, Hongchen, Xu, Shixiao, Yang, Tiezhao, Zhang, Xiaoquan, Su, Xinhong, Xia, Zongliang
Τόπος έκδοσης Front Plant Sci (2020)

Characterization and functional analysis of phytoene synthase gene family in tobacco

ανά Wang, Zhaojun, Zhang, Lin, Dong, Chen, Guo, Jinggong, Jin, Lifeng, Wei, Pan, Li, Feng, Zhang, Xiaoquan, Wang, Ran
Τόπος έκδοσης BMC Plant Biol (2021)

A phase I study to assess the mass balance, excretion, and pharmacokinetics of [(14)C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumors

ανά Gupta, Neeraj, Zhang, Steven, Pusalkar, Sandeepraj, Plesescu, Mihaela, Chowdhury, Swapan, Hanley, Michael J., Wang, Bingxia, Xia, Cindy, Zhang, Xiaoquan, Venkatakrishnan, Karthik, Shepard, Dale R.
Τόπος έκδοσης Invest New Drugs (2017)

A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end‐stage renal disease requiring haemodialysis

ανά Gupta, Neeraj, Hanley, Michael J., Harvey, R. Donald, Badros, Ashraf, Lipe, Brea, Kukreti, Vishal, Berdeja, Jesus, Yang, Huyuan, Hui, Ai‐Min, Qian, Mark, Zhang, Xiaoquan, Venkatakrishnan, Karthik, Chari, Ajai
Τόπος έκδοσης Br J Haematol (2016)

Effects of Strong CYP3A Inhibition and Induction on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor: Results of Drug‐Drug Interaction Studies in Patients With Advanc...

ανά Gupta, Neeraj, Hanley, Michael J., Venkatakrishnan, Karthik, Bessudo, Alberto, Rasco, Drew W., Sharma, Sunil, O'Neil, Bert H., Wang, Bingxia, Liu, Guohui, Ke, Alice, Patel, Chirag, Rowland Yeo, Karen, Xia, Cindy, Zhang, Xiaoquan, Esseltine, Dixie‐Lee, Nemunaitis, John
Τόπος έκδοσης J Clin Pharmacol (2017)

Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation s...

ανά Hou, Jian, Jin, Jie, Xu, Yan, Wu, Depei, Ke, Xiaoyan, Zhou, Daobin, Lu, Jin, Du, Xin, Chen, Xiequn, Li, Junmin, Liu, Jing, Gupta, Neeraj, Hanley, Michael J., Li, Hongmei, Hua, Zhaowei, Wang, Bingxia, Zhang, Xiaoquan, Wang, Hui, van de Velde, Helgi, Richardson, Paul G., Moreau, Philippe
Τόπος έκδοσης J Hematol Oncol (2017)